Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Clostridium difficile in patients attending tuberculosis hospitals in Cape Town, South Africa, 2014-2015.

Kullin BR, Reid S, Abratt V.

Afr J Lab Med. 2018 Dec 6;7(2):846. doi: 10.4102/ajlm.v7i2.846. eCollection 2018.

2.

Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.

Kullin B, Wojno J, Abratt V, Reid SJ.

Eur J Clin Microbiol Infect Dis. 2017 Jan;36(1):163-175. doi: 10.1007/s10096-016-2790-x. Epub 2016 Sep 30.

PMID:
27696234
3.

Characterisation of Clostridium difficile strains isolated from Groote Schuur Hospital, Cape Town, South Africa.

Kullin B, Brock T, Rajabally N, Anwar F, Vedantam G, Reid S, Abratt V.

Eur J Clin Microbiol Infect Dis. 2016 Oct;35(10):1709-18. doi: 10.1007/s10096-016-2717-6. Epub 2016 Jul 27.

PMID:
27465145
4.

A comparison of Clostridium difficile diagnostic methods for identification of local strains in a South African centre.

Rajabally N, Kullin B, Ebrahim K, Brock T, Weintraub A, Whitelaw A, Bamford C, Watermeyer G, Thomson S, Abratt V, Reid S.

J Med Microbiol. 2016 Apr;65(4):320-327. doi: 10.1099/jmm.0.000231. Epub 2016 Feb 9.

PMID:
26860329
5.

Prevalence of gastrointestinal pathogenic bacteria in patients with diarrhoea attending Groote Schuur Hospital, Cape Town, South Africa.

Kullin B, Meggersee R, D'Alton J, Galvao B, Rajabally N, Whitelaw A, Bamford C, Reid SJ, Abratt VR.

S Afr Med J. 2015 Jan 5;105(2):121-5. doi: 10.7196/samj.8654.

PMID:
26242530
6.

Corrigendum to: "Bacteroides fragilis RecA protein overexpression causes resistance to metronidazole." [Res. Microbiol. 161 (5) (2010) 346-354].

Steffens LS, Nicholson S, Paul LV, Nord CE, Patrick S, Abratt VR.

Res Microbiol. 2015 Jun;166(5):e1. doi: 10.1016/j.resmic.2010.07.001. Epub 2010 Jul 30. No abstract available.

7.

Molecular characterisation of ABC-type multidrug efflux systems in Bifidobacterium longum.

Moodley C, Reid SJ, Abratt VR.

Anaerobe. 2015 Apr;32:63-69. doi: 10.1016/j.anaerobe.2014.12.004. Epub 2014 Dec 18.

PMID:
25529295
8.

The occurrence of antibiotic resistance genes in drug resistant Bacteroides fragilis isolates from Groote Schuur Hospital, South Africa.

Meggersee R, Abratt V.

Anaerobe. 2015 Apr;32:1-6. doi: 10.1016/j.anaerobe.2014.11.003. Epub 2014 Nov 15.

PMID:
25460195
9.

The recA operon: A novel stress response gene cluster in Bacteroides fragilis.

Nicholson SA, Smalley D, Smith CJ, Abratt VR.

Res Microbiol. 2014 May;165(4):290-9. doi: 10.1016/j.resmic.2014.03.005. Epub 2014 Apr 2.

10.

A functional analysis of the formyl-coenzyme A (frc) gene from Lactobacillus reuteri 100-23C.

Kullin B, Tannock GW, Loach DM, Kimura K, Abratt VR, Reid SJ.

J Appl Microbiol. 2014 Jun;116(6):1657-67. doi: 10.1111/jam.12500. Epub 2014 Apr 3.

11.

Identification of a collagen type I adhesin of Bacteroides fragilis.

Galvão BP, Weber BW, Rafudeen MS, Ferreira EO, Patrick S, Abratt VR.

PLoS One. 2014 Mar 11;9(3):e91141. doi: 10.1371/journal.pone.0091141. eCollection 2014.

12.

Two multidrug-resistant clinical isolates of Bacteroides fragilis carry a novel metronidazole resistance nim gene (nimJ).

Husain F, Veeranagouda Y, Hsi J, Meggersee R, Abratt V, Wexler HM.

Antimicrob Agents Chemother. 2013 Aug;57(8):3767-74. doi: 10.1128/AAC.00386-13. Epub 2013 May 28.

13.

Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: insights into understanding the rarity of urolithiasis in the black group.

Magwira CA, Kullin B, Lewandowski S, Rodgers A, Reid SJ, Abratt VR.

J Appl Microbiol. 2012 Aug;113(2):418-28. doi: 10.1111/j.1365-2672.2012.05346.x. Epub 2012 Jun 18.

14.

Antibiotic resistance and adhesion potential of Bacteroides fragilis clinical isolates from Cape Town, South Africa.

Galvão BP, Meggersee RL, Abratt VR.

Anaerobe. 2011 Aug;17(4):142-6. doi: 10.1016/j.anaerobe.2011.02.009. Epub 2011 Apr 28.

PMID:
21530667
15.

Crystal structure of Type III glutamine synthetase: surprising reversal of the inter-ring interface.

van Rooyen JM, Abratt VR, Belrhali H, Sewell T.

Structure. 2011 Apr 13;19(4):471-83. doi: 10.1016/j.str.2011.02.001.

16.

The role of Bacteroides fragilis RecQ DNA helicases in cell survival after metronidazole exposure.

Paul L, Patrick S, Nord CE, Abratt V.

FEMS Microbiol Lett. 2011 Jun;319(2):125-32. doi: 10.1111/j.1574-6968.2011.02271.x. Epub 2011 Apr 18.

17.

Proteolysis of the type III glutamine synthetase from Bacteroides fragilis causes expedient crystal-packing rearrangements.

van Rooyen J, Belrhali H, Abratt V, Sewell BT.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Mar 1;67(Pt 3):358-63. doi: 10.1107/S1744309110053893. Epub 2011 Feb 25.

18.

Twenty-eight divergent polysaccharide loci specifying within- and amongst-strain capsule diversity in three strains of Bacteroides fragilis.

Patrick S, Blakely GW, Houston S, Moore J, Abratt VR, Bertalan M, Cerdeño-Tárraga AM, Quail MA, Corton N, Corton C, Bignell A, Barron A, Clark L, Bentley SD, Parkhill J.

Microbiology. 2010 Nov;156(Pt 11):3255-69. doi: 10.1099/mic.0.042978-0. Epub 2010 Sep 9.

19.

Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.

Abratt VR, Reid SJ.

Adv Appl Microbiol. 2010;72:63-87. doi: 10.1016/S0065-2164(10)72003-7. Review.

PMID:
20602988
20.

Crystallization of recombinant Bacteroides fragilis glutamine synthetase (GlnN) isolated using a novel and rapid purification protocol.

van Rooyen JM, Abratt VR, Belrhali H, Sewell BT.

Protein Expr Purif. 2010 Dec;74(2):211-6. doi: 10.1016/j.pep.2010.06.007. Epub 2010 Jun 22.

PMID:
20600942
21.

Bacteroides fragilis RecA protein overexpression causes resistance to metronidazole.

Steffens LS, Nicholson S, Paul LV, Nord CE, Patrick S, Abratt VR.

Res Microbiol. 2010 Jun;161(5):346-54. doi: 10.1016/j.resmic.2010.04.003. Epub 2010 May 12. Erratum in: Res Microbiol. 2015 Jun;166(5):e1. Res Microbiol. 2015 Jun;166(5):e1.

22.

Overexpression of the rhamnose catabolism regulatory protein, RhaR: a novel mechanism for metronidazole resistance in Bacteroides thetaiotaomicron.

Patel EH, Paul LV, Casanueva AI, Patrick S, Abratt VR.

J Antimicrob Chemother. 2009 Aug;64(2):267-73. doi: 10.1093/jac/dkp203. Epub 2009 Jun 13.

23.

Rhamnose catabolism in Bacteroides thetaiotaomicron is controlled by the positive transcriptional regulator RhaR.

Patel EH, Paul LV, Patrick S, Abratt VR.

Res Microbiol. 2008 Nov-Dec;159(9-10):678-84. doi: 10.1016/j.resmic.2008.09.002. Epub 2008 Sep 19.

PMID:
18848625
24.
25.

Lactobacillus gasseri Gasser AM63(T) degrades oxalate in a multistage continuous culture simulator of the human colonic microbiota.

Lewanika TR, Reid SJ, Abratt VR, Macfarlane GT, Macfarlane S.

FEMS Microbiol Ecol. 2007 Jul;61(1):110-20. Epub 2007 May 16.

26.

Three-dimensional structure of a type III glutamine synthetase by single-particle reconstruction.

van Rooyen JM, Abratt VR, Sewell BT.

J Mol Biol. 2006 Aug 25;361(4):796-810. Epub 2006 Jul 5.

PMID:
16879836
27.

Xylose utilization and short-chain fatty acid production by selected components of the intestinal microflora of a rodent pollinator (Aethomys namaquensis).

Johnson SA, Jackson S, Abratt VR, Wolfaardt GM, Cordero-Otero R, Nicolson SW.

J Comp Physiol B. 2006 Sep;176(7):631-41. Epub 2006 May 5.

PMID:
16676189
28.

A functional analysis of the Bifidobacterium longum cscA and scrP genes in sucrose utilization.

Kullin B, Abratt VR, Reid SJ.

Appl Microbiol Biotechnol. 2006 Oct;72(5):975-81. Epub 2006 Mar 8.

PMID:
16523284
29.

The Bifidobacterium longum NCIMB 702259T ctr gene codes for a novel cholate transporter.

Price CE, Reid SJ, Driessen AJ, Abratt VR.

Appl Environ Microbiol. 2006 Jan;72(1):923-6.

31.

Use of traditional African fermented beverages as delivery vehicles for Bifidobacterium lactis DSM 10140.

McMaster LD, Kokott SA, Reid SJ, Abratt VR.

Int J Food Microbiol. 2005 Jul 15;102(2):231-7.

PMID:
15992622
32.

Extensive DNA inversions in the B. fragilis genome control variable gene expression.

Cerdeño-Tárraga AM, Patrick S, Crossman LC, Blakely G, Abratt V, Lennard N, Poxton I, Duerden B, Harris B, Quail MA, Barron A, Clark L, Corton C, Doggett J, Holden MT, Larke N, Line A, Lord A, Norbertczak H, Ormond D, Price C, Rabbinowitsch E, Woodward J, Barrell B, Parkhill J.

Science. 2005 Mar 4;307(5714):1463-5.

33.

Sucrose utilisation in bacteria: genetic organisation and regulation.

Reid SJ, Abratt VR.

Appl Microbiol Biotechnol. 2005 May;67(3):312-21. Epub 2005 Jan 20. Review.

PMID:
15660210
34.

Induction of sucrose utilization genes from Bifidobacterium lactis by sucrose and raffinose.

Trindade MI, Abratt VR, Reid SJ.

Appl Environ Microbiol. 2003 Jan;69(1):24-32.

35.
36.

In-vitro antibiotic susceptibility and molecular analysis of anaerobic bacteria isolated in Cape Town, South Africa.

Koch CL, Derby P, Abratt VR.

J Antimicrob Chemother. 1998 Aug;42(2):245-8.

PMID:
9738844
37.
38.
39.

Mode of action of metronidazole and a Bacteroides fragilis metA resistance gene in Escherichia coli.

Dachs GU, Abratt VR, Woods DR.

J Antimicrob Chemother. 1995 Apr;35(4):483-96.

PMID:
7628983
40.

A reporter gene vector to investigate the regulation of glutamine synthetase in Bacteroides fragilis Bf1.

Abratt VR, Zappe H, Woods DR.

J Gen Microbiol. 1993 Jan;139(1):59-65.

PMID:
7680708
41.
42.

Induction and repair of DNA strand breaks in Bacteroides fragilis.

Abratt VR, Peak MJ, Peak JG, Santangelo JD, Woods DR.

Can J Microbiol. 1990 Jul;36(7):490-4.

PMID:
2224646
43.
44.

Nucleotide sequence and expression of a cloned Thiobacillus ferrooxidans recA gene in Escherichia coli.

Ramesar RS, Abratt V, Woods DR, Rawlings DE.

Gene. 1989 May 15;78(1):1-8.

PMID:
2504646
45.
46.

Supplemental Content

Loading ...
Support Center